Asthma Allergy &Pulmonary Associates, PC

Philadelphia, Pennsylvania PA 19107

0 studies enrolling now · 2 studies all time

What they study most

Asthma, COPD, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Studies at this site

• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. — Completed